Nevertheless, it is clear that there are different genetic contributions to AAV associated with PR3-ANCA to that associated with MPO-ANCA, and further studies are planned to address the genetics of these two conditions separately which may identify further disease specific genetic susceptibility loci. This evidence concerns the gene MPO and anti-neutrophil cytoplasmic antibody-associated vasculitis.